Levalbuterol tartrate
Modify Date: 2024-01-08 12:35:11
Levalbuterol tartrate structure
|
Common Name | Levalbuterol tartrate | ||
|---|---|---|---|---|
| CAS Number | 661464-94-4 | Molecular Weight | 628.71 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C30H48N2O12 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Levalbuterol tartrateLevosalbutamol tartrate(levalbuterol) is the R-enantiomer of the short-acting β2-adrenergic receptor agonist salbutamol. IC50 Value:Target: β2-adrenergic receptorLevosalbutamol and salbutamol produced significantly better bronchodilator responses than placebo. Both the drugs showed equivalent time-dependent bronchodilator responses as measured by area under curve for percent change in FEV(1) and FVC over 6h. The time to onset of action, mean maximum bronchodilator response and duration of bronchodilator response were similar between levosalbutamol and salbutamol [1]. |
| Name | 4-[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol,(2R,3R)-2,3-dihydroxybutanedioic acid |
|---|---|
| Synonym | More Synonyms |
| Description | Levosalbutamol tartrate(levalbuterol) is the R-enantiomer of the short-acting β2-adrenergic receptor agonist salbutamol. IC50 Value:Target: β2-adrenergic receptorLevosalbutamol and salbutamol produced significantly better bronchodilator responses than placebo. Both the drugs showed equivalent time-dependent bronchodilator responses as measured by area under curve for percent change in FEV(1) and FVC over 6h. The time to onset of action, mean maximum bronchodilator response and duration of bronchodilator response were similar between levosalbutamol and salbutamol [1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C30H48N2O12 |
|---|---|
| Molecular Weight | 628.71 |
| PSA | 187.78000 |
| Storage condition | 2-8℃ |
| Levalbuterol tartrate |
| Xopenex HFA |
| (2R,3R)-2,3-Dihydroxysuccinic acid - 2-(hydroxymethyl)-4-{(1R)-1-hydroxy-2-[(2-methyl-2-propanyl)amino]ethyl}phenol (1:2) |
| Butanedioic acid, 2,3-dihydroxy-, (2R,3R)-, compd. with (αR)-α-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-1,3-benzenedimethanol (1:2) |